XML 58 R45.htm IDEA: XBRL DOCUMENT v3.24.4
Merger Agrfeement (Details)
Sep. 30, 2024
USD ($)
TenX [Member]  
Merger Agreement [Line Items]  
Additional paid in capital $ 3,831,357
Net liabilities 395,515
Cash 163,500
Liabilities 559,015
Transaction costs 2,358,780
Citius Oncology [Member]  
Merger Agreement [Line Items]  
Cash 3,827,944
Receivables 33,180,961
Advanced addtional amount 3,800,111
Issuance of debt, equity or royalty financing $ 10,000,000
Citius Pharma [Member]  
Merger Agreement [Line Items]  
Owned percentage 92.30%
Public Rights [Member] | TenX [Member]  
Merger Agreement [Line Items]  
Transaction costs $ 1,077,062